Elevations in GDF15 are not limited to these physiological states and in the 20 years since its discovery, increases in the peptide have been reported in a variety of pathological conditions including aging, cardiac failure, chronic kidney disease, mitochondrial disease and malignancy [16, 17]. The gene discussed is GDF15; the disease is inborn mitochondrial metabolism disorder.